Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with a molecular formula of C 62 H 98 N 16 O 22 and a molecular weight of 1,419.53 g/mol (CAS 137525-51-0)
Most evidence comes from in vitro studies or small human trials, not large-scale randomized controlled trials
Nat Med 6: 13551361
The soap is used first in bathing to cleanse and begin the process of lightening or illumination, followed by the lotion which helps to moisturize, smooth, and maintain glow
Inhibitory effect of MD fraction on tumor metastasis: involvement of NK cell activation and suppression of intercellular adhesion molecule (ICAM)-1 expression in lung vascular endothelial cells
Regulatory Framework: Key FDA Guidance Documents for Nasal Sprays The foundation of nasal spray testing requirements in the United States is established by two primary FDA guidance documents, both from the Center for Drug Evaluation and Research (CDER): FDA CDER 2002 Nasal Spray and Inhalation Solution, Suspension and Spray Drug Products Chemistry, Manufacturing and Controls Documentation (CMC Guidance): Defines the CMC documentation requirements for new drug applications (NDAs) and abbreviated new drug applications (ANDAs) involving nasal spray and inhalation drug products
